1.41
Schlusskurs vom Vortag:
$1.31
Offen:
$1.36
24-Stunden-Volumen:
698.81K
Relative Volume:
2.20
Marktkapitalisierung:
$68.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-90.97M
KGV:
-0.7485
EPS:
-1.8837
Netto-Cashflow:
$-32.83M
1W Leistung:
+17.50%
1M Leistung:
-12.42%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Filana Therapeutics Inc Stock (FLNA) Company Profile
Firmenname
Filana Therapeutics Inc
Sektor
Branche
Telefon
512-501-2444
Adresse
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN
Compare FLNA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
FLNA
Filana Therapeutics Inc
|
1.41 | 63.28M | 0 | -90.97M | -32.83M | -1.8837 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Filana Therapeutics Inc Stock (FLNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
| 2021-04-27 | Eingeleitet | B. Riley Securities | Buy |
| 2021-02-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-01-10 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Filana Therapeutics Inc Aktie (FLNA) Neueste Nachrichten
Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser
FLNA Should I Buy - Intellectia AI
Filana Therapeutics (FLNA) Stock: Up +0.80%, Key Resistance at $1.32 2026-05-21Community Trade Ideas - Newser
FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
FLNA Stock Price, Quote & Chart | FILANA THERAPEUTICS INC (NASDAQ:FLNA) - ChartMill
MSN Money - MSN
Filana Therapeutics 1Q Loss/Shr 21c >FLNA - Moomoo
Filana Therapeutics (NASDAQ: FLNA) trims Q1 2026 loss, pivots simufilam to TSC epilepsy - Stock Titan
Filana Therapeutics Releases Q1 2026 Financial Results and Business Update on May 7, 2026 - geneonline.com
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update - The Manila Times
Cost cuts shrink Filana Therapeutics (NASDAQ: FLNA) Q1 2026 net loss - Stock Titan
Biotech with $86.6M cash says FDA hold keeps epilepsy trial on hold - Stock Titan
Cassava Sciences | 8-K: Current report - Moomoo
At a Madrid epilepsy meeting, Filana detailed why it’s testing simufilam - Stock Titan
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII - GlobeNewswire
MSN - MSN
[ARS] FILANA THERAPEUTICS, INC. SEC Filing - Stock Titan
Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan
Filana Therapeutics (FLNA) director O’Donnell to leave board after 2026 meeting - Stock Titan
How does Filana Therapeutics (FLNA) make money? (Market Focus) 2026-04-27Senior Analyst Forecasts - newser.com
Cassava Sciences (FLNA) Stock Price, News & Analysis $FLNA - MarketBeat
FLNA Filana Therapeutics posts narrower than expected Q3 2025 loss, shares edge higher in today’s trading.Trade Idea Marketplace - Newser
Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20Continuation Pattern - Xã Châu Thành
Finanzdaten der Filana Therapeutics Inc-Aktie (FLNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):